99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis (Annexin 03)
Phase II Study of 99mTc-rhAnnexin V-128 Radionuclide Imaging in Patients With Clinical Suspicion or Confirmed Diagnosis of Spondyloarthritis (SpA)
Sponsor: Advanced Accelerator Applications
Terminated
Sponsor Decision based on strategic considerations.
Other terminated trials from Advanced Accelerator Applications
Listed as NCT03232580, this PHASE2 trial focuses on Spondyloarthritis and remains terminated or withdrawn. Sponsored by Advanced Accelerator Applications, it has been updated 12 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Jan 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
Apr 2019 — Jan 2020 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Feb 2019 — Apr 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE2
-
Nov 2017 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Aug 2017 — Nov 2017 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Advanced Accelerator Applications
For direct contact, visit the study record on ClinicalTrials.gov .